{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&min-answer.questionFirstAnswered.=2015-01-09T13%3A48%3A20.34Z&max-answer.questionFirstAnswered.=2015-01-13T15%3A31%3A30.37Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?answeringDeptShortName=Health&min-answer.questionFirstAnswered.=2015-01-09T13%3A48%3A20.34Z&max-answer.questionFirstAnswered.=2015-01-13T15%3A31%3A30.37Z", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&min-answer.questionFirstAnswered.=2015-01-09T13%3A48%3A20.34Z&_metadata=all&max-answer.questionFirstAnswered.=2015-01-13T15%3A31%3A30.37Z", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&_page=0&min-answer.questionFirstAnswered.=2015-01-09T13%3A48%3A20.34Z&max-answer.questionFirstAnswered.=2015-01-13T15%3A31%3A30.37Z", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&min-answer.questionFirstAnswered.=2015-01-09T13%3A48%3A20.34Z&max-answer.questionFirstAnswered.=2015-01-13T15%3A31%3A30.37Z", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&min-answer.questionFirstAnswered.=2015-01-09T13%3A48%3A20.34Z&max-answer.questionFirstAnswered.=2015-01-13T15%3A31%3A30.37Z", "items" : [{"_about" : "http://data.parliament.uk/resources/172790", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/172790/answer", "answerText" : {"_value" : "

The Human Fertilisation and Embryology Authority (HFEA) has advised that in its 2014 report the Expert Panel, convened by the HFEA, concluded that, in relation to mosaicism in human morulae:<\/p>

<\/p>

<\/p>

<\/p>

\u201cAlthough experiments are already reported on ES cells and their derivatives with MST, further corroborative experiments would be valuable to demonstrate the degree of heteroplasmic mosaicism in morulae, and to provide data to address whether there was any amplification of mtDNA carried over.\u201d<\/p>

<\/p>

<\/p>

<\/p>

The Panel\u2019s report can be found on the HFEA\u2019s website at:<\/p>

<\/p>

<\/p>

<\/p>

http://www.hfea.gov.uk/6896.html<\/p>

<\/p>

<\/p>

<\/p>

The \u201calready reported\u201d experiments were published in Nature in 2013.<\/p>

<\/p>

<\/p>

<\/p>

At the time of writing the 2014 report, to the Panel\u2019s knowledge, this work had not been published in a peer-reviewed journal. The Department does not routinely publish scientific research conducted independently by others.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2015-01-13", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-01-13T15:21:10.37Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-01-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "IVF"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, whether the studies recommended by the Human Fertilisation and Embryology Authority's expert review panel in the publication, Scientific review of the safety and efficacy of methods to avoid mitochondrial disease through assisted conception: update, published in March 2013 on mosaicism in human morulae have been concluded; and in which peer-reviewed journal his Department plans to publish the findings of those studies.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3958", "label" : {"_value" : "Biography information for Fiona Bruce"} } , "tablingMemberConstituency" : {"_value" : "Congleton"} , "tablingMemberPrinted" : [{"_value" : "Fiona Bruce"} ], "uin" : "220195"} , {"_about" : "http://data.parliament.uk/resources/172797", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/172797/answer", "answerText" : {"_value" : "

There are already arrangements in place to support children born with conditions relating.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2015-01-13", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-01-13T15:16:23.13Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-01-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "IVF"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, whether he plans to put contingency arrangements in place to ensure support for recipients of mitochondrial donation techniques in the event of failure or abnormal development in the resulting child.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4126", "label" : {"_value" : "Biography information for Mary Glindon"} } , "tablingMemberConstituency" : {"_value" : "North Tyneside"} , "tablingMemberPrinted" : [{"_value" : "Mrs Mary Glindon"} ], "uin" : "220183"} , {"_about" : "http://data.parliament.uk/resources/172798", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/172798/answer", "answerText" : {"_value" : "

Neither the nuclear DNA or mitochondrial DNA of the patient\u2019s egg is altered during the creation of an embryo during mitochondrial donation treatment, using the maternal spindle transfer (MST) and pro-nuclear transfer (PNT) techniques.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2015-01-13", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-01-13T15:21:06.287Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-01-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "IVF"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what assessment his Department has made of whether eggs used in the creation of embryos through maternal spindle transfer or pronuclear transfer have had their mitochondrial or nuclear genes altered in the process.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4126", "label" : {"_value" : "Biography information for Mary Glindon"} } , "tablingMemberConstituency" : {"_value" : "North Tyneside"} , "tablingMemberPrinted" : [{"_value" : "Mrs Mary Glindon"} ], "uin" : "220181"} , {"_about" : "http://data.parliament.uk/resources/172801", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/172801/answer", "answerText" : {"_value" : "

The Health and Safety Executive (HSE) has run a number of asbestos related awareness raising campaigns including the \u2018Hidden Killer\u2019 campaign in 2008-09; the asbestos \u2018Training Pledge\u2019 in 2010; and the current \u2018Beware Asbestos\u2019 campaign.<\/p>

<\/p>

<\/p>

<\/p>

The \u2018Beware Asbestos\u2019 campaign was launched in October 2014 and is aimed at trades in which people who may disturb asbestos-containing materials in their day to day work. It includes information on identifying asbestos-containing materials and simple, easy to understand advice on how to avoid exposure to asbestos when carrying out a range of common work activities on such materials. It features a smartphone \u2018app\u2019 as a means of delivering this information to.<\/p>

<\/p>

<\/p>

<\/p>

HSE has guidance on the health risks from asbestos, including mesothelioma on its dedicated asbestos related web pages, together with comprehensive information on how to comply with the legal controls covering work with asbestos. This is available at<\/p>

<\/p>

<\/p>

<\/p>

www.hse.gov.uk/asbestos<\/a><\/p>

<\/p>

<\/strong><\/p>

<\/p>

Information about causes and symptoms of mesothelioma and advice on seeking help is also available on NHS Choices at<\/p>

<\/p>

<\/p>

www.nhs.uk/Livewell/Lungcancer/Pages/Asbestosandlungcancer.aspx<\/a><\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2015-01-13", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-01-13T15:08:07.217Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-01-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Mesothelioma"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what steps the Government is taking to raise awareness of mesothelioma and its cause by (a) exposure to asbestos and (b) other causes.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3931", "label" : {"_value" : "Biography information for Dr Julian Huppert"} } , "tablingMemberConstituency" : {"_value" : "Cambridge"} , "tablingMemberPrinted" : [{"_value" : "Dr Julian Huppert"} ], "uin" : "220226"} , {"_about" : "http://data.parliament.uk/resources/172802", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/172802/answer", "answerText" : {"_value" : "

The Human Fertilisation and Embryology Authority (HFEA) has advised that some relevant experiments have been carried out in the macaque a summary of which can be found at paragraph 2.3.4 of the 2013 report of the Expert Panel convened by the HFEA. The report can be found on the HFEA\u2019s website at:<\/p>

<\/p>

<\/p>

<\/p>

http://www.hfea.gov.uk/6896.html<\/p>

<\/p>

<\/p>

<\/p>

The results were published in Cell Reports in 2012.<\/p>

<\/p>

<\/p>

<\/p>

The use of non-human primate experiments was deemed by the Panel, in its 2013 and 2014 reports, to no longer be necessary.<\/p>

<\/p>

<\/p>

<\/p>

The Department does not routinely publish scientific research conducted independently by others.<\/p>

<\/p>

<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2015-01-13", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-01-13T15:09:38.837Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-01-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "IVF"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, whether the experiment on mitochondrial DNA carry-over on non-human primate model into the possible heteroplasmy of tissues in the foetus, recommended by the Human Fertilisation and Embryology Authority's expert panel in its publication Scientific review of the safety and efficacy of methods to avoid mitochondrial disease through assisted conception, published April 2011, has been concluded; and in which peer-reviewed journal he plans to publish the results of that experiment.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3958", "label" : {"_value" : "Biography information for Fiona Bruce"} } , "tablingMemberConstituency" : {"_value" : "Congleton"} , "tablingMemberPrinted" : [{"_value" : "Fiona Bruce"} ], "uin" : "220220"} , {"_about" : "http://data.parliament.uk/resources/172807", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/172807/answer", "answerText" : {"_value" : "

The Human Fertilisation and Embryology Authority (HFEA) has advised that at the time of writing its 2014 report the Expert Panel, convened by the HFEA, was not aware of results relating to the use of induced pluripotent stem cells derived from patients carrying different mitochondrial DNA mutations being published in a peer-reviewed journal.<\/p>

<\/p>

<\/p>

<\/p>

The Department does not routinely publish scientific research conducted independently by others.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2015-01-13", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-01-13T15:28:04.153Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-01-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "IVF"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, whether the experiment involving the use of induced pluripotent stem cells derived from patients carrying different mitochondrial DNA mutations, recommended by the Human Fertilisation and Embryology Authority's expert panel in its publication Scientific review of the safety and efficacy of methods to avoid mitochondrial disease through assisted conception, published April 2011, has been concluded; and in which peer-reviewed journal he plans to publish the results of that experiment.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3958", "label" : {"_value" : "Biography information for Fiona Bruce"} } , "tablingMemberConstituency" : {"_value" : "Congleton"} , "tablingMemberPrinted" : [{"_value" : "Fiona Bruce"} ], "uin" : "220219"} , {"_about" : "http://data.parliament.uk/resources/172443", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/172443/answer", "answerText" : {"_value" : "

United Kingdom citizens working with aid agencies and international relief organisations outside the UK, who remain ordinarily resident in the UK, will retain full entitlement to free NHS hospital treatment. For those not ordinarily resident in the UK, they will become so if they take up or resume settled residence in the UK, and will consequently be fully entitled again.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2015-01-12", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-01-12T15:15:15.457Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-01-07", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Ebola"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, pursuant to his Statement of 5 January 2015, Official Report, columns 38-40, on UK Ebola preparedness, whether the eligibility for full access to NHS care will be retained by UK citizens working with aid agencies and international relief organisations outside the UK.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/395", "label" : {"_value" : "Biography information for Lord Blunkett"} } , "tablingMemberConstituency" : {"_value" : "Sheffield, Brightside and Hillsborough"} , "tablingMemberPrinted" : [{"_value" : "Mr David Blunkett"} ], "uin" : "219990"} , {"_about" : "http://data.parliament.uk/resources/172529", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/172529/answer", "answerText" : {"_value" : "

The principle behind the treatment is that the mitochondrial DNA that the child will inherit will be the disease-free mitochondrial DNA of the donor, not the faulty mitochondrial DNA of their mother. Although there is a small possibility that a low level of unhealthy mitochondria may be carried over when the patient\u2019s nuclear DNA is moved from her egg or embryo to the donor\u2019s, evidence continues to be reassuring that carry-over after mitochondrial replacement is very low and unlikely to be problematic. Therefore, the risks of mitochondrial disease being present in the subsequent generation will be low.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2015-01-12", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "220108"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-01-12T17:43:57.943Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-01-07", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "IVF"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, pursuant to the Written Statement WS132 of 17 December 2014 on mitochondrial donation, whether the expert panel convened by the Human Fertilisation and Embryology Authority regarding mitochondrial transfer found that no females born following spindle-chromosomal complex transfer or pronuclear transfer would ever transmit the disease to subsequent generations.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3958", "label" : {"_value" : "Biography information for Fiona Bruce"} } , "tablingMemberConstituency" : {"_value" : "Congleton"} , "tablingMemberPrinted" : [{"_value" : "Fiona Bruce"} ], "uin" : "220129"} , {"_about" : "http://data.parliament.uk/resources/172530", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/172530/answer", "answerText" : {"_value" : "

The Human Fertilisation and Embryology Authority (HFEA) has advised that neither its members or executive have been in correspondence with the authors of the abstract referred to. However, a member of the Expert Panel convened by the HFEA had an email exchange with one of the authors regarding this abstract, which confirmed that the research group did not publish any further detail or follow up to this study. It would not be appropriate for a copy of this private correspondence to be placed in the Library.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2015-01-12", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-01-12T15:23:22.7Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-01-07", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "IVF"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, with reference to the letter from the Parliamentary Under-Secretary of State for Public Health to Lord Alton of Liverpool of 30 October 2014, if he will place in the Library a full copy of the correspondence between members of the expert panel convened by the Human Fertilisation and Embryology Authority and the Zhang research group referred to in that letter.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3958", "label" : {"_value" : "Biography information for Fiona Bruce"} } , "tablingMemberConstituency" : {"_value" : "Congleton"} , "tablingMemberPrinted" : [{"_value" : "Fiona Bruce"} ], "uin" : "220130"} , {"_about" : "http://data.parliament.uk/resources/172532", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/172532/answer", "answerText" : {"_value" : "

This information is not collected centrally.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"} } , "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"} , "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"} , "dateOfAnswer" : {"_value" : "2015-01-12", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-01-12T15:22:11.54Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-01-07", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Perinatal Mortality"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what the average incidence was of stillbirths and linked infant deaths in England and Wales in which all of the twins or triplets from the same pregnancy that remained after foetal reduction in either the first trimester or early in the second trimester subsequently died in infancy or were stillborn in each of the last 10 years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3958", "label" : {"_value" : "Biography information for Fiona Bruce"} } , "tablingMemberConstituency" : {"_value" : "Congleton"} , "tablingMemberPrinted" : [{"_value" : "Fiona Bruce"} ], "uin" : "220131"} ], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&_page=1&min-answer.questionFirstAnswered.=2015-01-09T13%3A48%3A20.34Z&max-answer.questionFirstAnswered.=2015-01-13T15%3A31%3A30.37Z", "page" : 0, "startIndex" : 1, "totalResults" : 92, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }